FDA geriatric labeling final rule has phased implementation schedule setting 2003 as final deadline.
FDA GERIATRIC LABELING FINAL RULE SETS 2003 DEADLINE for the addition of a geriatric use subsection to labeling for all applicable pharmaceuticals. The final rule becomes effective one year from the date of its publication in the Aug. 27 Federal Register, but its implementation will occur in phases over a five-year period.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth